Similarly, results from our xenograft study showed greater efficacy upon suppressing the rate of tumor growth when siRNA-IL-6 was combined with cisplatin as compared with siRNA-IL-6 or cisplatin treatment alone. Here, IL6 is linked to neoplasm.